Literature DB >> 10449494

Immunochromatographic strip-based detection of Entamoeba histolytica-E. dispar and Giardia lamblia coproantigen.

D R Pillai1, K C Kain.   

Abstract

BIOSITE Triage was 68.3% sensitive and 100% specific for the detection of Entamoeba histolytica-E. dispar (n = 71) compared to Alexon-Trend's ProSpecT test (reference standard) using fresh-frozen stool. Neither test is able to distinguish E. histolytica from E. dispar. Triage was 83.3% sensitive and 100% specific compared to microscopy (formalin-ether concentrates and permanent stains) for the detection of Giardia lamblia.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10449494      PMCID： PMC85440     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar.

Authors:  D Mirelman; Y Nuchamowitz; T Stolarsky
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Giardiasis in day-care centers: evidence of person-to-person transmission.

Authors:  R E Black; A C Dykes; S P Sinclair; J G Wells
Journal:  Pediatrics       Date:  1977-10       Impact factor: 7.124

3.  Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection.

Authors:  R Haque; I K Ali; S Akther; W A Petri
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 4.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

Authors:  J A Walsh
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

5.  Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of nonendemicity.

Authors:  D R Pillai; J S Keystone; D C Sheppard; J D MacLean; D W MacPherson; K C Kain
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates.

Authors:  S L Reed; B M Flores; M A Batzer; M A Stein; V L Stroeher; J E Carlton; D L Diedrich; B E Torian
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool.

Authors:  D G Addiss; H M Mathews; J M Stewart; S P Wahlquist; R M Williams; R J Finton; H C Spencer; D D Juranek
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

8.  Evaluation of an antigen capture enzyme-linked immunosorbent assay for detection of Cryptosporidium oocysts.

Authors:  R D Newman; K L Jaeger; T Wuhib; A A Lima; R L Guerrant; C L Sears
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  YI-S, a casein-free medium for axenic cultivation of Entamoeba histolytica, related Entamoeba, Giardia intestinalis and Trichomonas vaginalis.

Authors:  L S Diamond; C G Clark; C C Cunnick
Journal:  J Eukaryot Microbiol       Date:  1995 May-Jun       Impact factor: 3.346

Review 10.  A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

Authors:  L S Diamond; C G Clark
Journal:  J Eukaryot Microbiol       Date:  1993 May-Jun       Impact factor: 3.346
View more
  14 in total

Review 1.  Immunological methods for detection and identification of infectious disease and biological warfare agents.

Authors:  Anne Harwood Peruski; Leonard F Peruski
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Development of monoclonal antibodies which specifically recognize Entamoeba histolytica in preserved stool samples.

Authors:  Y C Yau; I Crandall; K C Kain
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Development and initial evaluation of a lateral flow dipstick test for antigen detection of Entamoeba histolytica in stool sample.

Authors:  Syazwan Saidin; Muhammad Hafiznur Yunus; Nurulhasanah Othman; Yvonne Ai-Lian Lim; Zeehaida Mohamed; Nik Zairi Zakaria; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2017-03-24       Impact factor: 2.894

4.  Evaluation of the Triage Micro Parasite Panel for detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens.

Authors:  S E Sharp; C A Suarez; Y Duran; R J Poppiti
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay.

Authors:  L S Garcia; R Y Shimizu; C N Bernard
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples.

Authors:  Joerg Blessmann; Heidrun Buss; Phuong A Ton Nu; Binh T Dinh; Quynh T Viet Ngo; An Le Van; Mohamed D Abd Alla; Terry F H G Jackson; Jonathan I Ravdin; Egbert Tannich
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 7.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 8.  Update on laboratory diagnosis of amoebiasis.

Authors:  Syazwan Saidin; Nurulhasanah Othman; Rahmah Noordin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-25       Impact factor: 3.267

Review 9.  Laboratory diagnostic techniques for Entamoeba species.

Authors:  R Fotedar; D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

10.  LUMINEX®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools.

Authors:  Helena Lúcia Carneiro Santos; Kakali Bandyopadhyay; Rebecca Bandea; Regina Helena Saramago Peralta; José Mauro Peralta; Alexandre Januário Da Silva
Journal:  Parasit Vectors       Date:  2013-03-15       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.